SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 155 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $722,000 | +13.9% | 76,760 | +54.5% | 0.00% | 0.0% |
Q2 2014 | $634,000 | -18.4% | 49,685 | -10.8% | 0.00% | 0.0% |
Q1 2014 | $777,000 | +14.3% | 55,724 | +15.3% | 0.00% | 0.0% |
Q4 2013 | $680,000 | +946.2% | 48,328 | +674.2% | 0.00% | – |
Q3 2013 | $65,000 | +32.7% | 6,242 | -0.8% | 0.00% | – |
Q2 2013 | $49,000 | – | 6,291 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
EMC Capital Management | 48,992 | $765,000 | 0.58% |
Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |